PubMed · 2007 · 19 citations · 0 references
Life SciencesCell BiologyCell SignalingSignal TransductionStem Cell BiologyExtracellular MatrixFocal AdhesionsMechanotransductionMesenchymal DifferentiationOsteogenesisStem Cell Signaling PathwaysBone Extracellular Matrix MineralizationCyclic StrainCyclic Strain SignalingFocal Adhesion Kinase SignalingMatrix MineralizationMechanical Signaling PathwaysOsteogenic DifferentiationOsteogenic Signaling Pathways
Focal adhesion kinase (FAK) is a key integrator of integrin-mediated signals from the extracellular matrix to the cytoskeleton and downstream signaling molecules. FAK is activated by phosphorylation at specific tyrosine residues, which then stimulate downstream signaling including the ERK1/2 pathway, leading to a variety of cellular responses. In this study, we examined the effects of FAK point mutations at tyrosine residues (Y397, Y925, Y861, and Y576/7) on osteogenic differentiation of human mesenchymal stem cells exposed to collagen I and cyclic tensile strain. Our results demonstrate that FAK signaling emanating from Y397, Y925, and to a lesser extent Y576/7, but not from Y861, controls osteogenic differentiation through an ERK1/2 pathway, as measured by expression levels of key osteogenesis marker genes and subsequent matrix mineralization. These data indicate that FAK is a critical decision maker in extracellular matrix/strain-enhanced osteogenic differentiation.